COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study
NCT06105320 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2023-10-27
Summary
A 2-arm (sequence), 2-period, 2-treatments, single blinded (outcome assessor), randomized crossover-trial (12+12 weeks with immediate contrast) comparing a low-carbohydrate-high-fat diet (LCHF) with a high-carbohydrate-low-fat diet (HCLF) among individuals with prodromal Alzheimer's disease.
Conditions
- Prodromal Alzheimer's Disease
- Alzheimer Disease
- Mild Cognitive Impairment
- Neurocognitive Disorders
Interventions
- OTHER
-
LCHF
A diet intervention with the following macronutrient targets: Carbohydrates: 10-25 E%; Fat 50-70 E%; Protein: 20-25 E%; Alcohol 0-5 E%
- OTHER
-
HCLF
A diet intervention with the following macronutrient targets: Carbohydrates: 50-60 E%; Fat 25-30 E%; Protein: 15-20 E%; Alcohol 0-5 E%
Sponsors & Collaborators
-
Fingers Brain Health Institute
collaborator OTHER - collaborator OTHER
-
af Jochnick Foundation
collaborator UNKNOWN -
Karolinska University Hospital
lead OTHER
Principal Investigators
-
Anne Börjesson-Hanson, MD, PhD · Karolinska University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-31
- Primary Completion
- 2025-10-31
- Completion
- 2026-04-30
Countries
- Sweden
Study Locations
More Related Trials
-
The Ketogenic Diet in the Treatment of Alzheimer's Disease
NCT06681948 ·Status: COMPLETED ·Phase: NA
-
Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease
NCT01055392 ·Status: UNKNOWN ·Phase: PHASE2
-
MIND Diet Intervention and Cognitive Decline
NCT02817074 ·Status: COMPLETED ·Phase: NA
-
European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
NCT00357357 ·Status: COMPLETED ·Phase: PHASE2
-
COGNIShunt® System for Alzheimer's Disease
NCT00056628 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Nutraceutic Compound on Cognitive Impairment
NCT06200883 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression
NCT06898424 ·Status: COMPLETED ·Phase: NA
-
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
NCT03472664 ·Status: RECRUITING ·Phase: NA
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
NCT02957682 ·Status: COMPLETED ·Phase: PHASE4
-
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
NCT01374438 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
NCT05122598 ·Status: UNKNOWN ·Phase: PHASE2
-
Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
NCT05007730 ·Status: COMPLETED ·Phase: NA
-
Donepezil Attenuate Postoperative Cognitive Dysfunction
NCT02927522 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men
NCT02010476 ·Status: COMPLETED
-
Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.
NCT04396015 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline
NCT03585907 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment
NCT05289804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reversal of Cognitive Decline (ReCODE) Study
NCT03883633 ·Status: COMPLETED
-
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
NCT02211560 ·Status: TERMINATED ·Phase: NA
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA